Despite the availability of advanced treatments, cancer remains the second leading cause of death worldwide. This is due to the many challenges prevailing in the research field and cancer therapy. Resistance to therapy and side effects provide major hindrances to recovery from cancer. As a result, in addition to the aim of killing cancer cells, the focus should also be on reducing or preventing side effects of the treatment. To enhance the effectiveness of cancer treatment, many researchers are studying drug delivery systems based on silk proteins: fibroin and sericin. These proteins have high biocompatibility, biodegradability, and ease of modification. Consequently, many researchers have developed several formulations of silk proteins such as scaffolds, nanoparticles, and hydrogels by combining them with other materials or drugs. This review summarizes the use of silk proteins in various forms in cancer research and therapy. The use of silk proteins to study cancer cells, to deliver cancer drugs to a target site, in cancer thermal therapy, and as an anti-cancer agent is described here.
KumariNBhargavaARathSN. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line. Life Sci2020; 260: 118291.
5.
KapałczyńskaMKolendaTPrzybyłaW, et al.2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Arch Med Sci2018; 14: 910–919. Epub ahead of print 2016. DOI: 10.5114/aoms.2016.63743.
6.
KucharczykKKaczmarekKJozefczakA, et al.Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres. Mater Sci Eng C2021; 120: 111654.
7.
QuWJiPHanX, et al.Highly biocompatible apigenin-loaded silk fibroin nanospheres: preparation, characterization, and anti-breast-cancer activity. Polymers2022; 15: 23.
8.
ZouXJiangZLiL, et al.Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer. Artif Cells Nanomed Biotechnol2021; 49: 83–95.
9.
LiXHouSChenJ, et al.Engineering silk sericin decorated zeolitic imidazolate framework-8 nanoplatform to enhance chemotherapy. Colloids Surf B Biointerfaces2021; 200: 111594.
10.
WangMDuYHuangH, et al.Silk fibroin peptide suppresses proliferation and induces apoptosis and cell cycle arrest in human lung cancer cells. Acta Pharmacol Sin2019; 40: 522–529.
11.
KumarJPMandalBB. Silk sericin induced pro-oxidative stress leads to apoptosis in human cancer cells. Food Chem Toxicol2019; 123: 275–287.
12.
NiuHXiaoJLouX, et al.Three-dimensional silk fibroin/chitosan based microscaffold for anticancer drug screening. Front Bioeng Biotechnol2022; 10: 800830.
13.
AbbottABondKChibaT, et al.Development of a mechanically matched silk scaffolded 3D clear cell renal cell carcinoma model. Mater Sci Eng C2021; 126: 112141.
14.
LiuJQiCTaoK, et al.Sericin/dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment. ACS Appl Mater Interfaces2016; 8: 6411–6422.
15.
DoblhoferEHeidebrechtAScheibelT. To spin or not to spin: spider silk fibers and more. Appl Microbiol Biotechnol2015; 99: 9361–9380.
16.
ScheibelT. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact2004; 3: 14.
17.
QiYWangHWeiK, et al.A Review of Structure Construction of Silk Fibroin Biomaterials from Single Structures to Multi-Level Structures. Int J Mol Sci2017; 18: 237.
18.
GouSHuangYSungJ, et al.Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases. Nanomed2019; 14: 2373–2378.
19.
FlorczakADeptuchTKucharczykK, et al.Systemic and local silk-based drug delivery systems for cancer therapy. Cancers2021; 13: 5389.
20.
KunzRIBrancalhãoRMCRibeiroLdFC, et al.Silkworm sericin: properties and biomedical applications. BioMed Res Int2016; 2016, 2016: 8175701–8175719.
21.
RajputSKSinghMK. Sericin – A Unique Biomaterial. IOSR-JPTE2015; 2: 29–35.
22.
NiuLYangSZhaoX, et al.Sericin inhibits MDA-MB-468 cell proliferation via the PI3K/Akt pathway in triple-negative breast cancer. Mol Med Rep2021; 23: 140.
23.
WangPHeHCaiR, et al.Cross-linking of dialdehyde carboxymethyl cellulose with silk sericin to reinforce sericin film for potential biomedical application. Carbohydr Polym2019; 212: 403–411.
24.
WangFWangYTianC, et al.Fabrication of the FGF1-functionalized sericin hydrogels with cell proliferation activity for biomedical application using genetically engineered Bombyx mori (B. mori) silk. Acta Biomater2018; 79: 239–252.
25.
KaewkornWLimpeanchobNTiyaboonchaiW, et al.Effects of silk sericin on the proliferation and apoptosis of colon cancer cells. Biol Res2012; 45: 45–50.
26.
JenaKPandeyJPKumariR, et al.Tasar silk fiber waste sericin: New source for anti-elastase, anti-tyrosinase and anti-oxidant compounds. Int J Biol Macromol2018; 114: 1102–1108.
27.
SanoMTamadaYNiwaK, et al.Sulfated Sericin is a Novel Anticoagulant influencing the blood Coagulation Cascade. J Biomater Sci Polym Ed2009; 20: 773–783.
28.
AramwitPKanokpanontSDe-EknamkulW, et al.Monitoring of inflammatory mediators induced by silk sericin. J Biosci Bioeng2009; 107: 556–561.
SukthamKKoobkokkruadTWutikhunT, et al.Efficiency of resveratrol-loaded sericin nanoparticles: promising bionanocarriers for drug delivery. Int J Pharm2018; 537: 48–56.
31.
SilvaASCostaECReisS, et al.Silk Sericin: a promising sustainable biomaterial for biomedical and pharmaceutical applications. Polymers2022; 14: 4931.
32.
FusterMGCarissimiGMontalbánMG, et al.Improving anticancer therapy with naringenin-loaded silk fibroin nanoparticles. Nanomaterials2020; 10: 718.
33.
FlorczakADeptuchTLewandowskaA, et al.Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo. J Nanobiotechnology2020; 18: 177.
34.
BuhomeOWongwattanakulMDaduangJ, et al.3D Silk Fibroin-Gelatin/Hyaluronic Acid/Heparan sulfate scaffold enhances expression of stemness and EMT markers in Cholangiocarcinoma. Vivo2022; 36: 1155–1167.
35.
MishraAMukhopadhyaySKDeyS. Evaluation of cyclosaplin efficacy using a silk based 3D tumor model. Biomolecules2019; 9: 123.
36.
PatwaRSoundararajanNMulchandaniN, et al.Silk nano-discs: a natural material for cancer therapy. Biopolymers2018; 109: e23231.
37.
PierantoniLRibeiroVPCostaL, et al.Horseradish peroxidase‐crosslinked calcium‐containing silk fibroin hydrogels as artificial matrices for bone cancer research. Macromol Biosci2021; 21: 2000425.
38.
DondajewskaEJuzwaWMackiewiczA, et al.Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment. Oncotarget2018; 9: 4935–4950.
39.
DuvalKGroverHHanL-H, et al.Modeling physiological events in 2D vs. 3D cell culture. Physiology2017; 32: 266–277.
40.
GurskiLAPetrelliNJJiaX, et al.3D matrices for anti-cancer drug testing and development. Oncol Issues2010; 25: 20–25.
41.
SuXChenLHanS, et al.Preparation and characterization of a novel triple composite scaffold containing silk fiborin, chitosan, and alginate for 3D culture of colonic carcinoma cells in vitro. Med Sci Monit2020; 26: e922935. Epub ahead of print 15 June 2020. DOI: 10.12659/MSM.922935.
42.
Al SaqrAWaniSUDGangadharappaHV, et al.Enhanced cytotoxic activity of docetaxel-loaded silk fibroin nanoparticles against breast cancer cells. Polymers2021; 13: 1416.
43.
TulayPGalamNAdaliT. The wonders of silk fibroin biomaterials in the treatment of breast cancer. Crit Rev Eukaryot Gene Expr2018; 28: 129–134.
44.
MurphyARKaplanDL. Biomedical applications of chemically-modified silk fibroin. J Mater Chem2009; 19: 6443–6450.
45.
HinesDJKaplanDL. Characterization of small molecule controlled release from silk films. Macromol Chem Phys2013; 214: 280–294.
46.
GustafsonJGreishKFrandsenJ, et al.Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Control Release2009; 140: 256–261.
47.
XiaX-XWangMLinY, et al.Hydrophobic drug-triggered self-assembly of nanoparticles from silk-elastin-like protein polymers for drug delivery. Biomacromolecules2014; 15: 908–914.
48.
Rnjak-KovacinaJDesRochersTMBurkeKA, et al.The effect of sterilization on silk fibroin biomaterial properties: the effect of sterilization on silk fibroin biomaterial. Macromol Biosci2015; 15: 861–874.
49.
GilESParkS-HHuX, et al.Impact of sterilization on the enzymatic degradation and mechanical properties of silk biomaterials: impact of sterilization on the enzymatic degradation. Macromol Biosci2014; 14: 257–269.
50.
HedhammarMBramfeldtHBarisT, et al.Sterilized recombinant spider silk fibers of low pyrogenicity. Biomacromolecules2010; 11: 953–959.
51.
KucharczykKFlorczakADeptuchT, et al.Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells. J Nanobiotechnology2020; 18: 56.
52.
RaduI-CZahariaCHudițăA, et al.In Vitro interaction of doxorubicin-loaded silk sericin nanocarriers with MCF-7 breast cancer cells leads to DNA damage. Polymers2021; 13: 2047.
53.
FusterMGCarissimiGMontalbánMG, et al.Antitumor activity of rosmarinic acid-loaded silk fibroin nanoparticles on HeLa and MCF-7 cells. Polymers2021; 13: 3169.
54.
SuyamudCPhetdeeCJaimalaiT, et al.Silk fibroin-coated liposomes as biomimetic nanocarrier for long-term release delivery system in cancer therapy. Molecules2021; 26: 4936.
55.
ArumugamMMurugesanBPandiyanN, et al.Electrospinning cellulose acetate/silk fibroin/Au-Ag hybrid composite nanofiber for enhanced biocidal activity against MCF-7 breast cancer cell. Mater Sci Eng C2021; 123: 112019.
56.
Bayat MokhtariRHomayouniTSBaluchN, et al.Combination therapy in combating cancer. Oncotarget2017; 8: 38022–38043.
57.
LiHTianJWuA, et al.Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma. Int J Nanomedicine2016; 11: 4373–4380.
58.
NorouziPMotasadizadehHAtyabiF, et al.Combination therapy of breast cancer by codelivery of doxorubicin and survivin siRNA using polyethylenimine modified silk fibroin nanoparticles. ACS Biomater Sci Eng2021; 7: 1074–1087.
59.
WuPLiuQWangQ, et al.Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth. Int J Nanomedicine2018; 13: 5405–5418.
60.
HuditaARaduICGalateanuB, et al.Bioinspired silk fibroin nano-delivery systems protect against 5-FU induced gastrointestinal mucositis in a mouse model and display antitumor effects on HT-29 colorectal cancer cells in vitro. Nanotoxicolo2021; 1–22: 1–22.
61.
TanMLiuWLiuF, et al.Silk fibroin-coated nanoagents for acidic lysosome targeting by a functional preservation strategy in cancer chemotherapy. Theranostics2019; 9: 961–973.
62.
YanCLiangJFangH, et al.Fabrication and evaluation of silk sericin-derived hydrogel for the release of the model drug berberine. Gels2021; 7: 23.
63.
MoinAWaniSUDOsmaniRA, et al.Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer. Drug Deliv2021; 28: 1626–1636.
64.
CaoHYangYShaoZ. Doxorubicin hydrochloride and curcumin loaded silk fibroin/hydroxypropylcellulose hydrogels for localized chemotherapy of cancer. J Control Release2015; 213: e39.
65.
LiXZhouJWuH, et al.Electrospun silk fibroin/polylactic-co-glycolic acid/black phosphorus nanosheets nanofibrous membrane with photothermal therapy potential for cancer. Molecules2022; 27: 4563.
66.
LiT-JHuangC-CRuanP-W, et al.In vivo anti-cancer efficacy of magnetite nanocrystal - based system using locoregional hyperthermia combined with 5-fluorouracil chemotherapy. Biomaterials2013; 34: 7873–7883.
67.
YangRHouMGaoY, et al.Biomineralization-inspired crystallization of manganese oxide on silk fibroin nanoparticles for in vivo MR/fluorescence Imaging-assisted Tri-modal therapy of cancer. Theranostics2019; 9: 6314–6333.
68.
SongWGregoryDAAl-janabiH, et al.Magnetic-silk/polyethyleneimine core-shell nanoparticles for targeted gene delivery into human breast cancer cells. Int J Pharm2019; 555: 322–336.
69.
YanL-PSilva-CorreiaJRibeiroVP, et al.Tumor Growth Suppression Induced by Biomimetic Silk Fibroin Hydrogels. Sci Rep2016; 6: 31037.
70.
RibeiroVPSilva-CorreiaJGonçalvesC, et al.Rapidly responsive silk fibroin hydrogels as an artificial matrix for the programmed tumor cells death. PLOS ONE2018; 13: e0194441.
71.
FlorczakAGrzechowiakIDeptuchT, et al.Silk particles as carriers of therapeutic molecules for cancer treatment. Materials2020; 13: 4946.
